BackFreeline Therapeutics Holdings plc Overview

Freeline Therapeutics Holdings plc Receivables

Track Freeline Therapeutics Holdings plc's receivables ($2.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.82M
↓ 4.76% YoYΔ $-141000.00 vs prior year quarter

Peer average

Loading

Freeline Therapeutics Holdings plc Receivables History

Loading

Freeline Therapeutics Holdings plc vs. peers: Receivables Comparison

Loading

Freeline Therapeutics Holdings plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Freeline Therapeutics Holdings plc (FRLN) FAQ

As of the most recent data (September 2023), FRLN shows a receivables of $2.8M. That compares with $3M in the prior-year period — down 4.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FRLN's receivables is now $2.8M (was $3M) — a 4.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Freeline Therapeutics Holdings plc is outperforming or lagging.

Tracking FRLN's receivables over time shows whether Freeline Therapeutics Holdings plc is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8M That compares with $3M in the prior-year period — down 4.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Freeline Therapeutics Holdings plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $2.8M) with ownership activity and broader fundamentals.

Freeline Therapeutics Holdings plc's receivables is $2.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.